title: Anisakis simplex: the activity of larval products on the complement system.
abstract: The effects of the larval products (crude extract and excretory-secretory) of Anisakis simplex on the classical and alternative pathways of human complement system were investigated. This could constitute a mechanism to evade host defences, similarly than in other parasitic diseases. The larval products showed a stronger effect on the classical pathway than on the alternative pathway. The most pronounced modulating effects were found for the excretory-secretory products. Chelation of bivalent cations (Ca(2+) or Mg(2+)) by these larval products may be responsible for their mode of action on the alternative pathway, whereas the chelation is not likely to be particularly involved in the anticomplementary activity found on the classical pathway. Detailed studies revealed that the larval products of A. simplex act at the level of the C3 and other complement components. Heating the crude parasite extract led to a notable loss of haemolysis inhibition activity, and the addition of PMSF (a serine protease inhibitor) also cause variation in the activity of the crude extract.
authors.affiliation: Departamento de Parasitología, Facultad de Farmacia, Universidad Complutense, Madrid, Spain.
authors.forename: P
authors.initials: P
authors.lastname: García-Hernández
authors.forename: M
authors.initials: M
authors.lastname: Rodero
authors.forename: C
authors.initials: C
authors.lastname: Cuéllar
mesh_terms: D000818:Animals; D017163:Anisakis / Q000737:chemistry / Q000276:immunology*; D002118:Calcium / Q000378:metabolism; D002614:Chelating Agents / Q000378:metabolism; D003176:Complement C3 / Q000276:immunology; D003170:Complement Pathway, Alternative / Q000187:drug effects / Q000276:immunology*; D003171:Complement Pathway, Classical / Q000187:drug effects / Q000276:immunology*; D004912:Erythrocytes / Q000378:metabolism; D006461:Hemolysis / Q000276:immunology; D006801:Humans; D007814:Larva / Q000737:chemistry / Q000276:immunology; D008274:Magnesium / Q000378:metabolism; D011480:Protease Inhibitors / Q000494:pharmacology; D011817:Rabbits; D012756:Sheep; D013696:Temperature; D013997:Time Factors; D014105:Tosyl Compounds / Q000494:pharmacology
chemical_list: D002614:Chelating Agents; D003176:Complement C3; D011480:Protease Inhibitors; D014105:Tosyl Compounds; C003614:4-toluenesulfonyl fluoride; D008274:Magnesium; D002118:Calcium